Patents for A61P 17 - Drugs for dermatological disorders (106,455)
02/2007
02/15/2007DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives
02/15/2007DE102005037499A1 Pyrazolderivate Pyrazole derivatives
02/15/2007DE102005036656A1 Pharmaceutical composition containing IKK-beta inhibitor and agent for treating inflammation or tumor of the skin, useful for topical treatment of e.g. inflamed skin and tumors of the eye
02/15/2007CA2618112A1 Pyridone compound
02/15/2007CA2618069A1 Dihydroxyanthraquinones and their use
02/15/2007CA2616831A1 Treatment of wounds using il-17b
02/14/2007EP1752156A1 Active oxygen eliminator and moisturizer containing wild watermelon extract
02/14/2007EP1752129A1 Compositions and methods for treating skin conditions
02/14/2007EP1750758A1 Use of factor viia for the treatment of burn traumas
02/14/2007EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases
02/14/2007EP1750669A1 Solid pharmaceutical form comprising an ltb4 antagonist
02/14/2007EP1750660A1 Topical cypress essential oil composition for stretch marks
02/14/2007EP1750653A1 Use of heat shock protein inhibitorsfor the reduction of hair growth
02/14/2007EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands
02/14/2007EP1485059B1 Topical dapsone for the treatment of acne
02/14/2007EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/14/2007EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors
02/14/2007EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases
02/14/2007EP1341790B1 Sulfonamido ether substituted imidazoquinolines
02/14/2007EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives
02/14/2007EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
02/14/2007EP1294715B1 Quinazoline ditosylate salt compounds
02/14/2007EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
02/14/2007EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
02/14/2007EP1171144B1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
02/14/2007EP1126836B1 Benzamide potassium channel inhibitors
02/14/2007EP1124959B1 Cell surface molecule-induced macrophage activation
02/14/2007EP1083929B1 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
02/14/2007EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
02/14/2007CN1913917A Pharmaceutical composition for thrombin peptide derivatives
02/14/2007CN1913903A Remedy for external use for skin and mucosal injuries caused by viral infection
02/14/2007CN1913888A Methods for reducing the effects of stress on skin condition
02/14/2007CN1912113A Protein and nuclein of antrodia camphoratu antioxidase and preparation method and use thereof
02/14/2007CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/14/2007CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels
02/14/2007CN1911442A Lysostaphin freeze dried powder used for preventing and treating trauma surface infestation
02/14/2007CN1911439A Orally administered peptides to ameliorate atherosclerosis
02/14/2007CN1911438A 血管新生诱导剂 Angiogenic inducer
02/14/2007CN1911417A Traditional Chinese medicine prescription for removing tragomaschalia and its prepn. method
02/14/2007CN1911412A External application traditional Chinese medicine for teating acne
02/14/2007CN1911398A Spraying prepn. of traditional Chinese medicine for recuperation of dermis after burns or scald, and its prepn. method
02/14/2007CN1911359A Medicinal distillate for treating acne
02/14/2007CN1911356A Ointment with aloe and other five medicinal herbs and its preparation method
02/14/2007CN1911351A Foot washing medicine for treating beri-beri, foot-sweat and foot-odour, and its prepn. method
02/14/2007CN1911331A Medicine prepn. for treating acne, and its prepn. method
02/14/2007CN1911328A Medicine for treating burns and scald
02/14/2007CN1911312A External application medicine for treating beri-beri
02/14/2007CN1911306A Ointment for treating beri-beri
02/14/2007CN1911302A Medicine composition for treating viral inflammation, and its prepn. method
02/14/2007CN1911238A Composite used for skin, and its application method
02/14/2007CN1911231A Medicine for treating burns
02/14/2007CN1911216A Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof
02/14/2007CN1300173C Human antibodies that bind huma TNF 'alpha'
02/14/2007CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
02/14/2007CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
02/14/2007CN1299750C Health article for nourishing Yin, enriching blood, and nourishing skin and hair and its preparing method
02/14/2007CN1299746C Chinese medicine for treating flat wart
02/14/2007CN1299737C Medicine for treating leukoderma and its preparing process
02/14/2007CN1299714C Method for preparing traditional Chinese compound ointment
02/14/2007CN1299704C Prescription of body surface shielding film and its preparing method
02/14/2007CN1299699C Chinese patent medicine for removing whelk
02/14/2007CN1299697C Chinese medicine preparation for treating acne and its preparing method
02/14/2007CN1299683C Celecoxib compositions
02/14/2007CN1299679C Preventive or remedy for bedsore
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors
02/13/2007US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors
02/13/2007US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives
02/13/2007US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases
02/13/2007US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity
02/13/2007US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved
02/13/2007US7176191 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin
02/13/2007US7175850 Formulation for topical non-invasive application in vivo
02/13/2007US7175842 Methods of modulating hair growth
02/13/2007CA2387198C Method for treating hair loss using thyromimetic compounds
02/08/2007WO2007015453A1 Lotion preparation containing pyridonecarboxylic acid derivative
02/08/2007WO2007015027A1 Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin
02/08/2007WO2007014711A1 17-alpha-substituted derivatives of estradiol with wound-healing activity
02/08/2007WO2006129161A3 Vitamin formulation
02/08/2007WO2006106220B1 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
02/08/2007WO2006087759A3 Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032518 Compounds and methods of use
02/08/2007US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
02/08/2007US20070032462 Novel methods for the preparation of dhea derivatives
02/08/2007US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
02/08/2007US20070032412 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031929 Polypeptides Homologous To VEGF and BMP1
02/08/2007US20070031478 Modified peptides and their uses
02/08/2007US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents
02/08/2007US20070031441 Immunotherapy based on dendritic cells
02/08/2007US20070031361 Cosmetic, pharmaceutical and dermatological preparations comprising homopolymer and/or copolymer waxes of the monomers ethylene and/or propylene
02/08/2007US20070031348 Use of oxygen in cosmetic or dermatological preparations
02/08/2007DE202006017031U1 Cosmetic or dermatological preparation, useful to treat e.g. skin aging, comprises e.g. vitamin-A, phytosterol, vitamin-E, urea, caprylic/capric triglyceride, lipid, thickener, emulsifier, polymer, perfume, preservatives and water
02/08/2007DE202006004676U1 Hautpflegeprodukte Skin care products
02/08/2007CA2617692A1 Combinations containing ikk-.beta. inhibitors